CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 35 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,629,000 | -3.2% | 1,137,764 | -12.9% | 0.28% | +9.6% |
| Q4 2021 | $3,750,000 | -39.7% | 1,306,626 | -16.6% | 0.25% | -33.4% |
| Q3 2021 | $6,222,000 | -33.4% | 1,567,326 | 0.0% | 0.38% | -25.8% |
| Q2 2021 | $9,341,000 | -43.1% | 1,567,326 | +15.9% | 0.51% | -30.7% |
| Q1 2021 | $16,417,000 | -15.2% | 1,352,313 | +1.5% | 0.73% | -46.7% |
| Q4 2020 | $19,353,000 | +30.2% | 1,332,397 | +1.5% | 1.38% | +28.7% |
| Q3 2020 | $14,864,000 | – | 1,313,286 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,501,716 | $17,284,000 | 8.25% |
| venBio Partners LLC | 3,673,374 | $42,281,000 | 6.42% |
| Omega Fund Management, LLC | 1,335,050 | $15,366,000 | 4.16% |
| Sofinnova Investments, Inc. | 3,606,707 | $41,513,000 | 3.08% |
| Novo Holdings A/S | 2,170,100 | $24,978,000 | 1.24% |
| CLOUGH CAPITAL PARTNERS L P | 1,313,286 | $14,864,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 600,687 | $6,914,000 | 0.59% |
| CAAS CAPITAL MANAGEMENT LP | 44,966 | $518,000 | 0.01% |
| Zimmer Partners, LP | 25,000 | $288,000 | 0.00% |
| Ensign Peak Advisors, Inc | 119,915 | $1,380,000 | 0.00% |